• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2021 ESC/EACTS Guidelines for the management of valvular heart disease.

作者信息

Vahanian Alec, Beyersdorf Friedhelm, Praz Fabien, Milojevic Milan, Baldus Stephan, Bauersachs Johann, Capodanno Davide, Conradi Lenard, De Bonis Michele, De Paulis Ruggero, Delgado Victoria, Freemantle Nick, Gilard Martine, Haugaa Kristina H, Jeppsson Anders, Jüni Peter, Pierard Luc, Prendergast Bernard D, Sádaba J Rafael, Tribouilloy Christophe, Wojakowski Wojtek

出版信息

Eur J Cardiothorac Surg. 2021 Oct 22;60(4):727-800. doi: 10.1093/ejcts/ezab389.

DOI:10.1093/ejcts/ezab389
PMID:34453161
Abstract
摘要

相似文献

1
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南。
Eur J Cardiothorac Surg. 2021 Oct 22;60(4):727-800. doi: 10.1093/ejcts/ezab389.
2
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
3
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):616-664. doi: 10.1093/ejcts/ezx324.
4
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
5
[ESC guidelines on the management of valvular heart disease. What has changed and what is new?].[欧洲心脏病学会瓣膜性心脏病管理指南。有哪些变化以及有哪些新内容？]
Herz. 2013 Dec;38(8):828-37. doi: 10.1007/s00059-013-3975-z.
6
[ESC/EACTS guidelines 2021 on the management of valvular heart diseases : What are the most important innovations?].[2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南：最重要的创新有哪些？]
Herz. 2022 Feb;47(1):19-30. doi: 10.1007/s00059-021-05068-5. Epub 2021 Oct 5.
7
[Whats new in ESC Guidelines for the management of valvular heart disease?].[欧洲心脏病学会瓣膜性心脏病管理指南有哪些新内容？]
Vnitr Lek. 2023 Summer;69(E-3):24-27. doi: 10.36290/vnl.2023.038.
8
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).《心脏瓣膜病管理指南（2012年版）》：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心脏瓣膜病管理联合工作组
Eur J Cardiothorac Surg. 2012 Oct;42(4):S1-44. doi: 10.1093/ejcts/ezs455. Epub 2012 Aug 25.
9
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 10;129(23):e521-643. doi: 10.1161/CIR.0000000000000031. Epub 2014 Mar 3.
10
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南：执行摘要：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 10;129(23):2440-92. doi: 10.1161/CIR.0000000000000029. Epub 2014 Mar 3.

引用本文的文献

1
TAVI plus PCI versus SAVR plus CABG: Long-term outcome of a multicentre-registry.经导管主动脉瓣植入术联合经皮冠状动脉介入治疗与外科主动脉瓣置换术联合冠状动脉旁路移植术：一项多中心注册研究的长期结果
Clin Res Cardiol. 2025 Sep 11. doi: 10.1007/s00392-025-02755-9.
2
Five-Year Survival After Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Valve Stenosis-Do We Choose the Right Treatment for Each Patient? A Propensity Score Matched Analysis.严重主动脉瓣狭窄患者经导管与外科主动脉瓣置换术后的五年生存率——我们是否为每位患者选择了正确的治疗方法？一项倾向评分匹配分析
J Pers Med. 2025 Aug 20;15(8):391. doi: 10.3390/jpm15080391.
3
Optimizing antithrombotic therapy following mitral valve repair: a comprehensive network meta-analysis.
二尖瓣修复术后抗栓治疗的优化：一项全面的网状Meta分析。
BMC Cardiovasc Disord. 2025 Aug 23;25(1):628. doi: 10.1186/s12872-025-04974-4.
4
Short- and Long-Term Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Patients With Chronic Lung Disease: An Analysis From the German Aortic Valve Registry.慢性肺病患者经导管或外科主动脉瓣置换术后的短期和长期预后：来自德国主动脉瓣注册研究的分析
Interdiscip Cardiovasc Thorac Surg. 2025 Aug 5;40(8). doi: 10.1093/icvts/ivaf189.
5
Refractory hypoxaemia in the presence of two common conditions: a case report.两种常见病症并存时的难治性低氧血症：一例病例报告
Eur Heart J Case Rep. 2025 Jul 15;9(8):ytaf327. doi: 10.1093/ehjcr/ytaf327. eCollection 2025 Aug.
6
Impact of mitral regurgitation severity on thromboembolic risk in atrial fibrillation: a comprehensive systematic review and meta-analysis.二尖瓣反流严重程度对心房颤动血栓栓塞风险的影响：一项全面的系统评价和荟萃分析。
Int J Cardiovasc Imaging. 2025 Aug 8. doi: 10.1007/s10554-025-03487-7.
7
Electrosurgical Laceration and Stabilization of Clip Followed by Transapical Mitral Valve Replacement after Failed Transcatheter Edge-to-Edge Mitral Valve Repair: A Promising Alternative to Surgery.经导管二尖瓣缘对缘修复失败后行电外科撕裂并固定夹子，随后行经心尖二尖瓣置换术：一种有前景的手术替代方案
Interdiscip Cardiovasc Thorac Surg. 2025 Aug 5;40(8). doi: 10.1093/icvts/ivaf183.
8
Society of cardiothoracic surgery in great Britain and Ireland guidance for adult mitral valve disease and interventions.英国和爱尔兰心胸外科协会关于成人二尖瓣疾病及干预措施的指南
BMJ Surg Interv Health Technol. 2025 Jul 23;7(1):e000328. doi: 10.1136/bmjsit-2024-000328. eCollection 2025.
9
Major Bleeding and Thromboembolic Events with the On-X Mechanical Aortic Valve Prosthesis: A SWEDEHEART Study.On-X机械主动脉瓣假体相关的大出血和血栓栓塞事件：一项瑞典心脏注册研究。
Interdiscip Cardiovasc Thorac Surg. 2025 Aug 5;40(8). doi: 10.1093/icvts/ivaf182.
10
Mechanical Versus Biological Bentall Procedure: A Propensity-Score Matching Analysis of 548 Consecutive Patients.机械瓣与生物瓣Bentall手术：548例连续患者的倾向评分匹配分析
J Clin Med. 2025 Jul 18;14(14):5105. doi: 10.3390/jcm14145105.